SMAGP a Novel Biomarker of Cervical Cancer Development and Progression [Erratum]

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s250149
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

A Novel Biomarker for Cervical Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2009English

Serum microRNA-205 as a Novel Biomarker for Cervical Cancer Patients

Cancer Cell International
Cancer ResearchOncologyGenetics
2014English

N-Cadherin, a Novel Prognostic Biomarker, Drives Malignant Progression of Colorectal Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

GSTM3 and GSTP1: Novel Players Driving Tumor Progression in Cervical Cancer

Oncotarget
Oncology
2018English

The Novel circCLK3/miR-320a/FoxM1 Axis Promotes Cervical Cancer Progression

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Metabolomics a Novel Biomarker in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

A Novel Biomarker for Diagnosis of Bladder Cancer

Folia Pharmacologica Japonica
Pharmacology
2015English

P190-B, a Novel RhoGAP, in Mammary Gland Development and Breast Cancer Progression

2006English

Comprehensive Gene and Pathway Analysis of Cervical Cancer Progression

Oncology Letters
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy